|
ARSK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
4.96840002472965E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
5.452000E-02 |
| Stage1-vs-Stage3 |
4.185800E-01 |
| Stage1-vs-Stage4 |
8.49070000000784E-05 |
| Stage2-vs-Stage3 |
2.661500E-02 |
| Stage2-vs-Stage4 |
1.395170E-04 |
| Stage3-vs-Stage4 |
2.663500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.98559999448267E-08 |
| Normal-vs-Asian |
4.44089209850063E-16 |
| Caucasian-vs-AfricanAmerican |
3.075200E-01 |
| Caucasian-vs-Asian |
8.651600E-01 |
| AfricanAmerican-vs-Asian |
4.885800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
8.039000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
4.607900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.968000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.062000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.403200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.929000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.952600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.347800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.00570000000278E-06 |
| Classical-VS-Follicular |
4.857600E-03 |
| Classical-VS-Other |
8.131200E-01 |
| Classical-VS-Normal |
4.44089209850063E-16 |
| Tall-VS-Follicular |
2.04650000279472E-08 |
| Tall-VS-Other |
3.070800E-01 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
2.946800E-01 |
| Follicular-VS-Normal |
2.44249065417534E-12 |
| Other-VS-Normal |
6.32229999999456E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.16939999994514E-06 |
|
|
